Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Acute leukemia successfully treated with natural interferon-alpha].

K Moriya1, N Miura, S Sunaga

  • 1First Department of Internal Medicine, Faculty of Medicine, University of Tokyo.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|February 1, 1991
PubMed
Summary

Natural interferon-alpha (IFN-alpha) effectively induced remission in a patient with acute leukemia resistant to conventional chemotherapy. This interferon therapy normalized blood counts and maintained remission for over seven months.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of post-trastuzumab deruxtecan treatments and incidence of interstitial lung disease in HER2-positive metastatic breast cancer: a real-world, observational cohort study.

ESMO open·2025
Same author

Effect of human adipose-derived mesenchymal stem cell conditioned medium on musculoskeletal pain.

European review for medical and pharmacological sciences·2022
Same author

Unique characteristics of community-onset healthcare- associated bloodstream infections: a multi-centre prospective surveillance study of bloodstream infections in Japan.

The Journal of hospital infection·2017
Same author

Increase in cortisol/ACTH ratio after chronic treatment with liraglutide in patients with type 2 diabetes.

Diabetes & metabolism·2017
Same author

Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia?

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2016
Same author

I.v. BU/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high-risk hematological diseases.

Bone marrow transplantation·2015

Area of Science:

  • Oncology
  • Immunology
  • Hematology

Background:

  • Acute leukemia presents with increased blast cells and often requires intensive chemotherapy.
  • Conventional chemotherapy regimens like BHAC-DMP and low-dose Ara-C can be ineffective in certain leukemia cases.
  • Interferon-alpha (IFN-alpha) is a cytokine with known immunomodulatory and antiproliferative effects.

Observation:

  • A 42-year-old male patient with acute leukemia presented with hypocellular bone marrow and 50% blast infiltration.
  • The patient's leukemia was refractory to initial treatment with BHAC-DMP and low-dose Ara-C chemotherapy.
  • Natural interferon-alpha (nIFN-alpha) was administered as a monotherapy.

Findings:

  • Treatment with nIFN-alpha resulted in a significant reduction of bone marrow blasts to below 3% within one month.

Related Experiment Videos

  • Peripheral blood cell counts normalized following nIFN-alpha therapy.
  • The patient achieved and maintained a complete remission for at least seven months.

    • Implications:

    • Natural interferon-alpha may represent a viable therapeutic option for acute leukemia refractory to standard chemotherapy.
    • IFN-alpha monotherapy demonstrates potential in inducing and sustaining long-term remission in leukemia patients.
    • Further investigation into interferon-based therapies for hematological malignancies is warranted.